ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,054.08
      -0.15%
      US Tech 100
      17,235.60
      -0.04%
      Dow Jones
      37,847.88
      0.30%
      Brent Oil
      89.42
      -0.51%
      Bitcoin
      62,726.60
      -1.10%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Medicinova Inc (MNOV)

      7. Medicinova Inc (MNOV) News

      MNOV

      Medicinova (MNOV)

      Medicinova Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MNOV
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
      04/02/20247:00PMGlobeNewswire Inc.MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)NASDAQ:MNOVMedicinova Inc
      03/26/20247:00PMGlobeNewswire Inc.MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in JapanNASDAQ:MNOVMedicinova Inc
      03/20/20247:00PMGlobeNewswire Inc.MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis SocietyNASDAQ:MNOVMedicinova Inc
      03/12/20246:30AMGlobeNewswire Inc.MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of ToxicologyNASDAQ:MNOVMedicinova Inc
      02/15/20244:25PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MNOVMedicinova Inc
      01/19/20244:27PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MNOVMedicinova Inc
      01/19/20244:25PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MNOVMedicinova Inc
      01/19/20244:23PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MNOVMedicinova Inc
      01/19/20244:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MNOVMedicinova Inc
      01/17/20246:00AMGlobeNewswire Inc.MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in ChinaNASDAQ:MNOVMedicinova Inc
      01/11/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
      01/11/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
      01/11/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
      12/21/20236:00PMGlobeNewswire Inc.MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of ToxicologyNASDAQ:MNOVMedicinova Inc
      12/06/20236:00PMGlobeNewswire Inc.MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in EuropeNASDAQ:MNOVMedicinova Inc
      11/20/20237:42AMIH Market NewsStocks Set to Open Higher as Investors Await FOMC Minutes and Nvidia EarningsNASDAQ:MNOVMedicinova Inc
      11/19/20236:00PMGlobeNewswire Inc.MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-OncologyNASDAQ:MNOVMedicinova Inc
      11/09/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNOVMedicinova Inc
      10/27/20231:00AMGlobeNewswire Inc.MediciNova’s Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of PhenylketonuriaNASDAQ:MNOVMedicinova Inc
      10/10/20237:00PMGlobeNewswire Inc.MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in CanadaNASDAQ:MNOVMedicinova Inc
      10/04/20237:00PMGlobeNewswire Inc.MediciNova Receives Gene Therapy Milestone PaymentNASDAQ:MNOVMedicinova Inc
      09/27/20237:00PMGlobeNewswire Inc.MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung InjuryNASDAQ:MNOVMedicinova Inc
      08/17/20237:00PMGlobeNewswire Inc.MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the Annual Meeting of the Society for Neuro-OncologyNASDAQ:MNOVMedicinova Inc
      08/16/20237:00PMGlobeNewswire Inc.MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in EuropeNASDAQ:MNOVMedicinova Inc
      08/15/20237:00PMGlobeNewswire Inc.MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in EuropeNASDAQ:MNOVMedicinova Inc
      08/14/20237:00PMGlobeNewswire Inc.MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in EuropeNASDAQ:MNOVMedicinova Inc
      08/09/20234:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNOVMedicinova Inc
      08/08/20234:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
      08/08/20234:17PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MNOVMedicinova Inc
       Showing the most relevant articles for your search:NASDAQ:MNOV